Release Date: 29/08/19 08:13 Summary: FY19 Results Release Announcement Price Sensitive: Yes Download Document 867.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%